The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study-Reference-Cited by-同舟云学术

The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study

Published:2016-06-27 Issue:6 Volume:11 Page:e0157721
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

D’Amico Emanuele,Leone Carmela,Graziano Giusi,Amato Maria Pia,Bergamaschi Roberto,Cavalla Paola,Coniglio Gabriella,Di Battista Giancarlo,Ferrò Maria Teresa,Granella Franco,Granieri Enrico,Lugaresi Alessandra,Lus Giacomo,Millefiorini Enrico,Pozzilli Carlo,Tedeschi Gioacchino,Zappia Mario,Comi Giancarlo,Trojano Maria,Lepore Vito,Patti Francesco

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference27 articles.

1. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies;DM Wingerchuk;Mayo Clin Proc,2014

2. Role of the innate and adaptive immune responses in the course of multiple sclerosis;B Hemmer;Lancet Neurol,2015

3. Role of immunosuppressive therapy for the treatment of multiple sclerosis;JM Stankiewicz;Neurotherapeutics,2013

4. New FDA-Approved Disease-Modifying Therapies for Multiple Sclerosis;C English;Clin Ther,2015

5. Mitoxantrone for multiple sclerosis;F Martinelli Boneschi;Cochrane Database Syst Rev,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple Sclerosis—A Demyelinating Disorder and Its Dental Considerations—A Literature Review with Own Case Report;Brain Sciences;2023-06-29

2. Juvenile Idiopathic Arthritis, Uveitis and Multiple Sclerosis: Description of Two Patients and Literature Review;Biomedicines;2022-08-21

3. Impact of National List of Essential Medicines (NLEM) on Cost Variation of Immunosuppressants available in Indian Market;Journal of Young Pharmacists;2022-08-17

4. Radiological and Laboratory Features of Multiple Sclerosis Patients With Immunosuppressive Therapy: A Multicenter Retrospective Study in Japan;Frontiers in Neurology;2021-10-13

5. Cancer risk for multiple sclerosis patients treated with azathioprine and disease-modifying therapies: an Italian observational study;Neurological Sciences;2021-03-31